Åkerblom, Axel
86  Ergebnisse:
Personensuche X
?
1

Safety and efficacy of the 5-lipoxygenase-activating protei..:

Prescott, Eva ; Angerås, Oskar ; Erlinge, David...
International Journal of Cardiology.  365 (2022)  - p. 34-40 , 2022
 
?
3

Effects of 6 weeks of treatment with dapagliflozin, a sodiu..:

Oldgren, Jonas ; Laurila, Sanna ; Åkerblom, Axel...
Diabetes, Obesity and Metabolism.  23 (2021)  7 - p. 1505-1517 , 2021
 
?
 
?
6

Design and rationale of FLAVOUR: A phase IIa efficacy study..:

Prescott, Eva ; Pernow, John ; Saraste, Antti...
Contemporary Clinical Trials Communications.  19 (2020)  - p. 100629 , 2020
 
?
 
?
10

Prevalence and relevance of abnormal glucose metabolism in ..:

the PLATO Investigators ; Åkerblom, Axel ; Wojdyla, Daniel...
Journal of Thrombosis and Thrombolysis.  48 (2019)  4 - p. 563-569 , 2019
 
?
11

Pentraxin-3 vs C-reactive protein and other prognostic biom..:

Kontny, Frederic ; Andersen, Thomas ; Ueland, Thor...
European Heart Journal: Acute Cardiovascular Care.  9 (2019)  4 - p. 313-322 , 2019
 
?
13

Effects of DAPAgliflozin on CARDiac substrate uptake, myoca..:

Åkerblom, Axel ; Oldgren, Jonas ; Latva-Rasku, Aino...
Upsala Journal of Medical Sciences.  124 (2019)  1 - p. 59-64 , 2019
 
?
14

Osteoprotegerin Is Associated With Major Bleeding But Not W..:

Ueland, Thor ; Åkerblom, Axel ; Ghukasyan, Tatevik...
Journal of the American Heart Association.  7 (2018)  2 - p. , 2018
 
1-15